Anti-Myc-tag mAb-Agarose

Co-IP

1. Uenaka T et al. In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson's disease. Hum Mol Genet. 27, 3974-3985 (2018)(PMID:30137437)

Immunoprecipitation

1. Kato K et al. Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice. Mol Cell 53, 617-30 (2014)(PMID:24560272)
2. Ono R et al. PDLIM1 inhibits NF-κB-mediated inflammatory signaling by sequestering the p65 subunit of NF-κB in the cytoplasm. Sci Rep. 5, 18327 (2015)(PMID:26679095)
3. D'Lima NG et al. A human microprotein that interacts with the mRNA decapping complex. Nat Chem Biol. 13, 174-180 (2017)(PMID:27918561)
4. Shin C et al. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses. Sci Rep. 7, 46097 (2017)(PMID:28378844)
5. Saito K et al. PODXL1 promotes metastasis of the pancreatic ductal adenocarcinoma by activating the C5aR/C5a axis from the tumor microenvironment. Neoplasia. 21, 1121-1132 (2019)(PMID:31759250)
6. Jodo A et al. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB. Front Immunol. 11, 1559 (2020)(PMID:32849529)